| Original language | English |
|---|---|
| Number of pages | 1 |
| Journal | Journal of Cardiology |
| Volume | 74 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2019 Aug 1 |
Fingerprint
Clinical Trials
tolvaptan
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Tanaka, T., Kawana, M., & Kosaka, S. (2019). Interpreting the evidence from tolvaptan clinical trials. Journal of Cardiology, 74(2). https://doi.org/10.1016/j.jjcc.2019.02.018
Interpreting the evidence from tolvaptan clinical trials. / Tanaka, Toshikazu; Kawana, Masataka; Kosaka, Shun.
In: Journal of Cardiology, Vol. 74, No. 2, 01.08.2019.Research output: Contribution to journal › Letter
Tanaka, T, Kawana, M & Kosaka, S 2019, 'Interpreting the evidence from tolvaptan clinical trials', Journal of Cardiology, vol. 74, no. 2. https://doi.org/10.1016/j.jjcc.2019.02.018
Tanaka T, Kawana M, Kosaka S. Interpreting the evidence from tolvaptan clinical trials. Journal of Cardiology. 2019 Aug 1;74(2). https://doi.org/10.1016/j.jjcc.2019.02.018
@article{a87ae026951d43ff8bfc69efa2e8e06f,
title = "Interpreting the evidence from tolvaptan clinical trials",
author = "Toshikazu Tanaka and Masataka Kawana and Shun Kosaka",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jjcc.2019.02.018",
language = "English",
volume = "74",
journal = "Journal of cardiography. Supplement",
issn = "0914-5087",
publisher = "Japanese College of Cardiology (Nippon-Sinzobyo-Gakkai)",
number = "2",
}
TY - JOUR
T1 - Interpreting the evidence from tolvaptan clinical trials
AU - Tanaka, Toshikazu
AU - Kawana, Masataka
AU - Kosaka, Shun
PY - 2019/8/1
Y1 - 2019/8/1
UR - http://www.scopus.com/inward/record.url?scp=85066756974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066756974&partnerID=8YFLogxK
U2 - 10.1016/j.jjcc.2019.02.018
DO - 10.1016/j.jjcc.2019.02.018
M3 - Letter
C2 - 30948184
AN - SCOPUS:85066756974
VL - 74
JO - Journal of cardiography. Supplement
JF - Journal of cardiography. Supplement
SN - 0914-5087
IS - 2
ER -